742 Chapter | 24 Lysosomal Storage Diseases C . Gene Therapy The most striking clinical results <strong>of</strong> gene therapy involving an LSD have been those seen in a series <strong>of</strong> neonatal gene transfer studies conducted using viral vectors in the murine and canine models <strong>of</strong> MPS VII documenting significant improvement <strong>of</strong> cornea, joint, and cardiac disease ( Daly et al. , 1999, 2001 ; Ponder et al. , 2002 ; Xu et al. , 2002a , 2002b). In spite <strong>of</strong> the rarity <strong>of</strong> MPS VII (1/250,000 live births in humans), these disease models have become a paradigm for LSDs in general because <strong>of</strong> the ability to detect the normal enzyme (β-glucuronidase) activity directly using a histochemical technique. Intracranial injection <strong>of</strong> vector carrying the feline alpha mannosidase gene has produced remarkable clinical improvement in affected cats ( Vite et al. , 2005 ). ACKNOWLEDGMENTS The authors wish to thank Dr. Donald F. Patterson for his vision and for establishing the first Section <strong>of</strong> Medical Genetics in a veterinary school; Dr. Peter Jezyk for developing a metabolic screening laboratory for animals; Mr. James Hayden for the illustrations; Ms. Ping Wang, Ms. Marisa Van Hoeven, and Ms. Angie Huff for metabolic and enzyme analyses; Drs. Cathy Just and Meg Weil; Ms. Patricia O’Donnell; many Medical Genetics residents; and a cadre <strong>of</strong> veterinary students for animal care. Supported by NIH grants RR02512, DK25795, and DK54481. REFERENCES Abbitt , B. , Jones , M. Z. , Kasari , T. R. , Storts , R. W. , Templeton , J. W. , Holland , P. S. , and Castenson , P. E. ( 1991 ). Beta-mannosidosis in twelve Salers calves . J. Am. Vet. Med. Assoc. 198 , 109 – 113 . Aguirre , G. , Raber , I. , Yan<strong>of</strong>f , M. , and Haskins , M. ( 1992 ). Reciprocal corneal transplantation fails to correct mucopolysaccharidosis VI corneal storage . Invest. Ophthalmol. Vis. Sci. 33 , 2702 – 2713 . Ahern-Rindell , A. J. , Murnane , R. D. , and Prieur , D. J. ( 1988 a ). Betagalactosidase activity in fibroblasts and tissues from sheep with a lysosomal storage disease . Biochem. Genet. 26 , 733 – 746 . Ahern-Rindell , A. J. , Murnane , R. D. , and Prieur , D. J. ( 1989 ). Interspecific genetic complementation analysis <strong>of</strong> human and sheep fibroblasts with beta-galactosidase deficiency . Somat. Cell. Mol. Genet. 15 , 525 – 533 . Ahern-Rindell , A. J. , Prieur , D. J. , Murnane , R. D. , Raghavan , S. S. , Daniel , P. F. , McCluer , R. H. , Walkley , S. U. , and Parish , S. M. ( 1988 b ). Inherited lysosomal storage disease associated with deficiencies <strong>of</strong> beta-galactosidase and alpha-neuraminidase in sheep . Am. J. Med. Genet. 31 , 39 – 56 . Alroy , J. , Haskins , M. , and Birk , D. E. ( 1999 ). Altered corneal stromal matrix organization is associated with mucopolysaccharidosis I, III and VI . Exp. Eye. Res. 68 , 523 – 530 . Alroy , J. , Orgad , U. , DeGasperi , R. , Richard , R. , Warren , C. D. , Knowles , K. , Thalhammer , J. G. , and Raghavan , S. S. ( 1992 ). Canine GM1-gangliosidosis: a clinical, morphologic, histochemical, and biochemical comparison <strong>of</strong> two different models . Am. J. Pathol. 140 , 675 – 689 . Alroy , J. , Orgad , U. , Ucci , A. A. , Schelling , S. H. , Schunk , K. L. , Warren , C. D. , Raghavan , S. S. , and Kolodny , E. H. ( 1985 ). Neurovisceral and skeletal GM1-gangliosidosis in dogs with beta-galactosidase deficiency . Science 229 , 470 – 472 . Appleby , E. C. , Longstaffe , J. A. , and Bell , F. R. (1982 ). Ceroid-lip<strong>of</strong>uscinosis in two Saluki dogs . J. Comp. Pathol. 92 , 375 –380 . Aronovich , E. L. , Johnston , J. M. , Wang , P. , Giger , U. , and Whitley , C. B. ( 2001 ). Molecular basis <strong>of</strong> mucopolysaccharidosis type IIIB in emu (Dromaius novaehollandiae): an avian model <strong>of</strong> Sanfilippo syndrome type B . Genomics 74 , 299 – 305 . Austin , J. , Armstrong , D. , and Margolis , G. ( 1968 ). Studies <strong>of</strong> globoid leukodystrophy in dogs . Neurology 18 , 300 . Awano , T. , Katz , M. L. , O’Brien , D. P. , Sohar , I. , Lobel , P. , Coates , J. R. , Khan , S. , Johnson , G. C. , Giger , U. , and Johnson , G. S. ( 2006 a ). A frame shift mutation in canine TPP1 (the ortholog <strong>of</strong> human CLN2) in a juvenile Dachshund with neuronal ceroid lip<strong>of</strong>uscinosis . Mol. Genet. Metab. 89, 254–260. Awano , T. , Katz , M. L. , O’Brien , D. P. , Taylor , J. F. , Evans , J. , Khan , S. , Sohar , I. , Lobel , P. , and Johnson , G. S. ( 2006 b ). A mutation in the cathepsin D gene (CTSD) in American Bulldogs with neuronal ceroid lip<strong>of</strong>uscinosis . Mol. Genet. Metab. 87 , 341 – 348 . Baker , H. J. , Jr. , Lindsey , J. R. , McKhann , G. M. , and Farrell , D. F. (1971 ). Neuronal GM1 gangliosidosis in a Siamese cat with betagalactosidase deficiency . Science 174 , 838 – 839 . Baker , H. J. , Mole , J. A. , Lindsey , J. R. , and Creel , R. M. ( 1976 ). Animal models <strong>of</strong> human ganglioside storage diseases . Fed. Proc. 35 , 1193 – 1201 . Berman, L., Foureman, P., Stieger, K., Van Hoeven, M., Ellinwood, N. M., Henthorn, P. S., Thrall, M. A., Kirkness, E., Haskins, M. E., and Giger, U. (2004). Mucopolysaccharidosis type VI caused by a point mutation in the miniature pinscher and deletion in the miniature schnauzer. In “ 2nd International Conference: Advances in Canine and Feline Genomics, ” p. 60. Utrecht, The Netherlands. Bernheimer , H. , and Karbe , E. ( 1970 ). [Morphological and neurochemical investigations <strong>of</strong> 2 types <strong>of</strong> amaurotic idiocy in the dog: evidence <strong>of</strong> a GM2-gangliosidosis] . Acta Neuropathol. (Berl.) 16 , 243 – 261 . Bhaumik , M. , Muller , V. J. , Rozaklis , T. , Johnson , L. , Dobrenis , K. , Bhattacharyya , R. , Wurzelmann , S. , Finamore , P. , Hopwood , J. J. , Walkley , S. U. , and Stanley , P. ( 1999 ). A mouse model for mucopolysaccharidosis type III A (Sanfilippo syndrome) . Glycobiology 9 , 1389 – 1396 . Birkenmeier , E. H. , Davisson , M. T. , Beamer , W. G. , Ganschow , R. E. , Vogler , C. A. , Gwynn , B. , Lyford , K. A. , Maltais , L. M. , and Wawrzyniak , C. J. ( 1989 ). Murine mucopolysaccharidosis type VII: characterization <strong>of</strong> a mouse with beta-glucuronidase deficiency . J. Clin. Invest. 83 , 1256 – 1258 . Blakemore , W. F. ( 1972 ). GM-1 gangliosidosis in a cat . J. Comp. Pathol 82 , 179 – 185 . Bosshard , N. U. , Hubler , M. , Arnold , S. , Briner , J. , Spycher , M. A. , Sommerlade , H. J. , von Figura , K. , and Gitzelmann , R. ( 1996 ). Spontaneous mucolipidosis in a cat: an animal model <strong>of</strong> human I-cell disease . Vet. Pathol. 33 , 1 – 13 . Boysen , B. G. , Tryphonas , L. , and Harries , N. W. ( 1974 ). Globoid cell leukodystrophy in the bluetick hound dog. I. <strong>Clinical</strong> manifestations . Can. Vet. J. 15 , 303 – 308 . Brochstein , J. A. ( 1992 ). Bone marrow transplantation for genetic disorders . Oncology (Huntingt.) 6 , 51 – 58 .
References 743 Broom , M. F. , Zhou , C. , Broom , J. E. , Barwell , K. J. , Jolly , R. D. , and Hill , D. F. ( 1998 ). Ovine neuronal ceroid lip<strong>of</strong>uscinosis: a large animal model syntenic with the human neuronal ceroid lip<strong>of</strong>uscinosis variant CLN6 . J. Med. Genet. 35 , 717 – 721 . Bryan , L. , Schmutz , S. , Hodges , S. D. , and Snyder , F. F. ( 1993 ). Bovine beta-mannosidosis: pathologic and genetic findings in Salers calves . Vet. Pathol. 30 , 130 – 139 . Bundza , A. , Lowden , J. A. , and Charlton , K. M. ( 1979 ). Niemann-Pick disease in a poodle dog . Vet. Pathol. 16 , 530 – 538 . Burditt , L. J. , Chotai , K. , Hirani , S. , Nugent , P. G. , Winchester , B. G. , and Blakemore , W. F. ( 1980 ). Biochemical studies on a case <strong>of</strong> feline mannosidosis . Biochem. J. 189 , 467 – 473 . Castagnaro , M. ( 1990 ). Lectin histochemistry <strong>of</strong> the central nervous system in a case <strong>of</strong> feline alpha-mannosidosis . Res. Vet. Sci. 49 , 375 – 377 . Cho , D. Y. , Leipold , H. W. , and Rudolph , R. ( 1986 ). Neuronal ceroidosis (ceroid-lip<strong>of</strong>uscinosis) in a Blue Heeler dog . Acta Neuropathol. 69 , 161 – 164 . Chrisp , C. E. , Ringler , D. H. , Abrams , G. D. , Radin , N. S. , and Brenkert , A. ( 1970 ). Lipid storage disease in a Siamese cat . J. Am. Vet. Med. Assoc. 156 , 616 – 622 . Cook , R. W. , Jolly , R. D. , Palmer , D. N. , Tammen , I. , Broom , M. F. , and McKinnon , R. ( 2002 ). Neuronal ceroid lip<strong>of</strong>uscinosis in Merino sheep . Aust. Vet. J. 80 , 292 – 297 . Cork , L. C. , Munnell , J. F. , and Lorenz , M. D. ( 1978 ). The pathology <strong>of</strong> feline GM2 gangliosidosis . Am. J. Pathol. 90 , 723 – 734 . Cork , L. C. , Munnell , J. F. , Lorenz , M. D. , Murphy , J. V. , Baker , H. J. , and Rattazzi , M. C. (1977 ). GM2 ganglioside lysosomal storage disease in cats with beta-hexosaminidase deficiency . Science 196 , 1014 – 1017 . Cowell , K. R. , Jezyk , P. F. , Haskins , M. E. , and Patterson , D. F. ( 1976 ). Mucopolysaccharidosis in a cat . J. Am. Vet. Med. Assoc. 169 , 334 – 339 . Crawley , A. C. , Jones , M. Z. , Bonning , L. E. , Finnie , J. W. , and Hopwood , J. J. (1999 ). Alpha-mannosidosis in the guinea pig: a new animal model for lysosomal storage disorders . Pediatr. Res. 46 , 501 –509 . Crawley , A. C. , Yogalingam , G. , Muller , V. J. , and Hopwood , J. J. (1998 ). Two mutations within a feline mucopolysaccharidosis type VI colony cause three different clinical phenotypes . J. Clin. Invest. 101 , 109 –119 . Cummings , J. F. , Wood , P. A. , de Lahunta , A. , Walkley , S. U. , and Le Boeuf , L. ( 1988 ). The clinical and pathologic heterogeneity <strong>of</strong> feline alpha-mannosidosis . J. Vet. Intern. Med. 2 , 163 – 170 . Cummings , J. F. , Wood , P. A. , Walkley , S. U. , de Lahunta , A. , and DeForest , M. E. ( 1985 ). GM2 gangliosidosis in a Japanese spaniel . Acta Neuropathol. 67 , 247 – 253 . Daly , T. M. , Ohlemiller , K. K. , Roberts , M. S. , Vogler , C. A. , and Sands , M. S. ( 2001 ). Prevention <strong>of</strong> systemic clinical disease in MPS VII mice following AAV-mediated neonatal gene transfer . Gene Ther. 8 , 1291 – 1298 . Daly , T. M. , Vogler , C. , Levy , B. , Haskins , M. E. , and Sands , M. S. ( 1999 ). Neonatal gene transfer leads to widespread correction <strong>of</strong> pathology in a murine model <strong>of</strong> lysosomal storage disease . Proc. Natl. Acad. Sci. USA 96 , 2296 – 2300 . Di Natale , P. , Annella , T. , Daniele , A. , Spagnuolo , G. , Cerundolo , R. , de Caprariis , D. , and Gravino , A. E. ( 1992 ). Animal models for lysosomal storage diseases: a new case <strong>of</strong> feline mucopolysaccharidosis VI . J. Inherit. Metab. Dis. 15 , 17 – 24 . Dierks , T. , Dickmanns , A. , Preusser-Kunze , A. , Schmidt , B. , Mariappan , M. , von Figura , K. , Ficner , R. , and Rudolph , M. G. ( 2005 ). Molecular basis for multiple sulfatase deficiency and mechanism for formylglycine generation <strong>of</strong> the human formylglycine-generating enzyme . Cell 121 , 541 – 552 . Distler , J. , Hieber , V. , Sahagian , G. , Schmickel , R. , and Jourdian , G. W. ( 1979 ). Identification <strong>of</strong> mannose 6-phosphate in glycoproteins that inhibit the assimilation <strong>of</strong> beta-galactosidase by fibroblasts . Proc. Natl. Acad. Sci. USA 76 , 4235 – 4239 . Dobrenis , K. , Wenger , D. A. , and Walkley , S. U. ( 1994 ). Extracellular release <strong>of</strong> lysosomal glycosidases in cultures <strong>of</strong> cat microglia . Molec. Biol. Cell 5 , 113a Donnelly , W. J. , Sheahan , B. J. , and Kelly , M. (1973a ). Beta-galactosidase deficiency in GM1 gangliosidosis <strong>of</strong> Friesian calves . Res. Vet. Sci. 15 , 139 – 141 . Donnelly , W. J. , Sheahan , B. J. , and Rogers , T. A. ( 1973 b ). GM1 gangliosidosis in Friesian calves . J. Pathol. 111 , 173 – 179 . Duchen , L. W. , Eicher , E. M. , Jacobs , J. M. , Scaravilli , F. , and Teixeira , F. (1980 ). Hereditary leucodystrophy in the mouse: the new mutant twitcher . Brain 103 , 695 – 710 . Ellinwood , N. M. , Henthorn , P. S. , Giger , U. , and Haskins , M. E. ( 2002 ). Characterization <strong>of</strong> the normal cDNA for the canine N -acetyl- α -Dglucosaaminidase gene, the gene defective in mucopolysaccharidosis IIIB . Am. J. Hum. Genet. 71 ( suppl ) , 420 . Ellinwood , N. M. , Vite , C. H. , and Haskins , M. E. ( 2004 ). Gene therapy for lysosomal storage diseases: the lessons and promise <strong>of</strong> animal models . J. Gene. Med. 6 , 481 – 506 . Ellinwood , N. M. , Wang , P. , Skeen , T. , Sharp , N. , Cesta , M. , Bush , W. , Hardam , E. , Haskins , M. E. , and Giger , U. ( 2001 ). Characterization <strong>of</strong> a canine model <strong>of</strong> mucopolysaccharidosis IIIB . Am. J. Hum. Genet. 69 , 1760 . Ellinwood , N. M. , Wang , P. , Skeen , T. , Sharp , N. J. , Cesta , M. , Decker , S. , Edwards , N. J. , Bublot , I. , Thompson , J. N. , Bush , W. , Hardam , E. , Haskins , M. E. , and Giger , U. (2003 ). A model <strong>of</strong> mucopolysaccharidosis IIIB (Sanfilippo syndrome type IIIB): N-acetyl-alpha-D-glucosaminidase deficiency in Schipperke dogs . J. Inherit. Metab. Dis. 26 , 489 –504 . Embury , D. H. , and Jerrett , I. V. ( 1985 ). Mannosidosis in Galloway calves . Vet. Pathol. 22 , 548 – 551 . Fankhauser , R. , Luginbuhl , H. , and Hartley , W. J. ( 1963 ). Leukodystrophie vom Typus Krabbe beim Hund . Schweiz. Arch. Tierheilk. 105 , 198 – 207 . Farrell , D. F. , Baker , H. J. , Herndon , R. M. , Lindsey , J. R. , and McKhann , G. M. (1973 ). Feline GM 1 gangliosidosis: biochemical and ultrastructural comparisons with the disease in man . J. Neuropathol. Exp. Neurol. 32 , 1 – 18 . Farrow , B. R. , Hartley , W. J. , Pollard , A. C. , Fabbro , D. , Grabowski , G. A. , and Desnick , R. J. ( 1982 ). Gaucher disease in the dog . Prog. Clin. Biol. Res. 95 , 645 – 653 . Fischer , A. , Carmichael , K. P. , Munnell , J. F. , Jhabvala , P. , Thompson , J. N. , Matalon , R. , Jezyk , P. F. , Wang , P. , and Giger , U. ( 1998 ). Sulfamidase deficiency in a family <strong>of</strong> dachshunds: a canine model <strong>of</strong> mucopolysaccharidosis IIIA (Sanfilippo A) . Pediatr. Res. 44 , 74 – 82 . Fletcher , T. F. , and Kurtz , H. J. ( 1972 ). Animal model: globoid cell leukodystrophy in the dog . Am. J. Pathol. 66 , 375 – 378 . Fletcher , T. F. , Kurtz , H. J. , and Low , D. G. ( 1966 ). Globoid cell leukodystrophy (Krabbe type) in the dog . J. Am. Vet. Med. Assoc. 149 , 165 – 172 . Fletcher , T. F. , Lee , D. G. , and Hammer , R. F. ( 1971 ). Ultrastructural features <strong>of</strong> globoid-cell leukodystrophy in the dog . Am. J. Vet. Res. 32 , 177 – 1781 . Foureman , P. , Berman , L. , Stieger , K. , Van Hoeven , M. , Ellinwood , N. M. , Haskins , M. E. , Kirkness , E. , and Giger , U. ( 2004 ).
- Page 1 and 2:
Preface It has been more than a dec
- Page 3 and 4:
viii Contributors Björn P. Meij (5
- Page 5 and 6:
2 Chapter | 1 Concepts of Normality
- Page 7 and 8:
4 Chapter | 1 Concepts of Normality
- Page 9 and 10:
6 Chapter | 1 Concepts of Normality
- Page 11 and 12:
8 Chapter | 1 Concepts of Normality
- Page 13 and 14:
10 Chapter | 1 Concepts of Normalit
- Page 15 and 16:
12 Chapter | 1 Concepts of Normalit
- Page 17 and 18:
14 Chapter | 1 Concepts of Normalit
- Page 19 and 20:
16 Chapter | 1 Concepts of Normalit
- Page 21 and 22:
18 Chapter | 1 Concepts of Normalit
- Page 23 and 24:
20 Chapter | 1 Concepts of Normalit
- Page 25 and 26:
22 Chapter | 1 Concepts of Normalit
- Page 27 and 28:
24 Chapter | 1 Concepts of Normalit
- Page 29 and 30:
Chapter 2 Comparative Medical Genet
- Page 31 and 32:
I. Introduction 29 Green Red Green
- Page 33 and 34:
I. Introduction 31 A1 genetic map d
- Page 35 and 36:
I. Introduction 33 of genomes of va
- Page 38 and 39:
36 Chapter | 2 Comparative Medical
- Page 40 and 41:
38 Chapter | 2 Comparative Medical
- Page 42 and 43:
40 Chapter | 2 Comparative Medical
- Page 44 and 45:
42 Chapter | 2 Comparative Medical
- Page 46 and 47:
44 Chapter | 2 Comparative Medical
- Page 48 and 49:
46 Chapter | 3 Carbohydrate Metabol
- Page 50 and 51:
48 Chapter | 3 Carbohydrate Metabol
- Page 52 and 53:
50 Chapter | 3 Carbohydrate Metabol
- Page 54 and 55:
52 Chapter | 3 Carbohydrate Metabol
- Page 56 and 57:
54 Chapter | 3 Carbohydrate Metabol
- Page 58 and 59:
56 Chapter | 3 Carbohydrate Metabol
- Page 60 and 61:
58 Chapter | 3 Carbohydrate Metabol
- Page 62 and 63:
60 Chapter | 3 Carbohydrate Metabol
- Page 64 and 65:
62 Chapter | 3 Carbohydrate Metabol
- Page 66 and 67:
64 Chapter | 3 Carbohydrate Metabol
- Page 68 and 69:
66 Chapter | 3 Carbohydrate Metabol
- Page 71 and 72:
IX. Disorders of Carbohydrate Metab
- Page 73 and 74:
IX. Disorders of Carbohydrate Metab
- Page 75 and 76:
IX. Disorders of Carbohydrate Metab
- Page 77 and 78:
X. Disorders of Ruminants Associate
- Page 79 and 80:
X. Disorders of Ruminants Associate
- Page 81 and 82:
References 79 Kaneko , J. J. , Luic
- Page 83 and 84:
Chapter 4 Lipids and Ketones Michae
- Page 85 and 86:
II. Long Chain Fatty Acids 83 FIGUR
- Page 87 and 88:
II. Long Chain Fatty Acids 85 Plasm
- Page 89 and 90:
IV. Phospholipids 87 The regulation
- Page 91 and 92:
V. Cholesterol 89 V. CHOLESTEROL A.
- Page 93 and 94:
VI. Lipoproteins 91 TABLE 4-1 Compo
- Page 95 and 96:
VI. Lipoproteins 93 TABLE 4-2 Apoli
- Page 98 and 99:
96 Chapter | 4 Lipids and Ketones B
- Page 100 and 101:
98 Chapter | 4 Lipids and Ketones
- Page 102 and 103:
100 Chapter | 4 Lipids and Ketones
- Page 104 and 105:
102 Chapter | 4 Lipids and Ketones
- Page 106 and 107:
104 Chapter | 4 Lipids and Ketones
- Page 108 and 109:
106 Chapter | 4 Lipids and Ketones
- Page 110 and 111:
108 Chapter | 4 Lipids and Ketones
- Page 112 and 113:
110 Chapter | 4 Lipids and Ketones
- Page 114 and 115:
112 Chapter | 4 Lipids and Ketones
- Page 116 and 117:
114 Chapter | 4 Lipids and Ketones
- Page 118 and 119:
Chapter 5 Proteins, Proteomics, and
- Page 120 and 121:
III. Metabolism of Proteins 119 C .
- Page 122 and 123:
IV. Plasma Proteins 121 NH 4 HCO
- Page 124 and 125:
V. Methodology 123 molecule. The gl
- Page 126 and 127:
V. Methodology 125 has occurred wil
- Page 128 and 129:
V. Methodology 127 Although attempt
- Page 130 and 131:
V. Methodology 129 kD 94 67 43 2 2
- Page 132 and 133:
V. Methodology 131 D . Specific Pro
- Page 134 and 135:
VI. Normal Plasma and Serum Protein
- Page 136 and 137:
VI. Normal Plasma and Serum Protein
- Page 138 and 139:
VI. Normal Plasma and Serum Protein
- Page 140 and 141:
VI. Normal Plasma and Serum Protein
- Page 142 and 143:
VI. Normal Plasma and Serum Protein
- Page 144 and 145:
VII. Interpretation of Serum Protei
- Page 146 and 147:
VII. Interpretation of Serum Protei
- Page 148 and 149:
VII. Interpretation of Serum Protei
- Page 150 and 151:
References 149 Andersson , M. , Ste
- Page 152 and 153:
References 151 response of haptoglo
- Page 154 and 155:
References 153 dogs with metastasiz
- Page 156 and 157:
References 155 Watson , T. D. G. (
- Page 158:
158 Chapter | 6 Clinical Veterinary
- Page 163 and 164:
V. Methods for Evaluation of the Im
- Page 165 and 166:
V. Methods for Evaluation of the Im
- Page 167 and 168:
V. Methods for Evaluation of the Im
- Page 169:
VI. Laboratory Diagnosis of Disease
- Page 173 and 174:
Chapter 7 The Erythrocyte: Physiolo
- Page 175 and 176:
II. Hematopoiesis 175 progenitor ce
- Page 177 and 178:
III. Developing Erythroid Cells 177
- Page 179 and 180:
III. Developing Erythroid Cells 179
- Page 181 and 182:
III. Developing Erythroid Cells 181
- Page 183 and 184:
III. Developing Erythroid Cells 183
- Page 185 and 186:
IV. Mature RBC 185 immune-mediated
- Page 187 and 188:
IV. Mature RBC 187 TABLE 7-3 Erythr
- Page 189 and 190:
IV. Mature RBC 189 TABLE 7.5 Erythr
- Page 191 and 192:
IV. Mature RBC 191 Echinocyte forma
- Page 193 and 194:
IV. Mature RBC 193 Pig RBC isoantig
- Page 195 and 196:
IV. Mature RBC 195 occurs in chicke
- Page 197 and 198:
IV. Mature RBC 197 inorganic phosph
- Page 199 and 200:
IV. Mature RBC 199 (a) FIGURE 7-6 T
- Page 201 and 202:
IV. Mature RBC 201 RBC 2,3DPG incre
- Page 203 and 204:
IV. Mature RBC 203 mechanisms would
- Page 205 and 206:
IV. Mature RBC 205 released during
- Page 207 and 208:
IV. Mature RBC 207 reduced by ascor
- Page 209 and 210:
V. Determinants of RBC Survival 209
- Page 211 and 212:
V. Determinants of RBC Survival 211
- Page 213 and 214:
VI. Inherited Disorders of RBCs 213
- Page 215 and 216:
VI. Inherited Disorders of RBCs 215
- Page 217 and 218:
VI. Inherited Disorders of RBCs 217
- Page 219 and 220:
described in people. They include a
- Page 221 and 222:
References 221 Boas , F. E. , Forma
- Page 223 and 224:
References 223 Della Rovere , F. ,
- Page 225 and 226:
References 225 Gedde , M. M. , Davi
- Page 227 and 228:
References 227 phosphofructokinase-
- Page 229 and 230:
References 229 Knight , A. P. , Las
- Page 231 and 232:
References 231 Martinovich , D. , a
- Page 233 and 234:
References 233 Pearson , W. , Boerm
- Page 235 and 236:
References 235 Shadduck , R. K. ( 1
- Page 237 and 238:
References 237 Tennant , B. , Dill
- Page 239 and 240:
References 239 Williams , D. M. , L
- Page 241 and 242:
Chapter 8 Porphyrins and the Porphy
- Page 243 and 244:
II. Porphyrins 243 two vinyl groups
- Page 245 and 246:
II. Porphyrins 245 TABLE 8-2 Nomenc
- Page 247 and 248:
IV. Porphyrias 247 6. Uroporphyrins
- Page 249 and 250:
IV. Porphyrias 249 i . Urine It is
- Page 251 and 252:
IV. Porphyrias 251 to localize the
- Page 253 and 254:
IV. Porphyrias 253 FIGURE 8-6 Metab
- Page 255 and 256:
IV. Porphyrias 255 estrogens. The d
- Page 257 and 258:
References 257 and hexachlorobenzen
- Page 259 and 260:
Chapter 9 Iron Metabolism and Its D
- Page 261 and 262:
II. Iron Distribution 261 plasma of
- Page 263 and 264:
IV. Plasma Iron Transport 263 pathw
- Page 265 and 266:
VI. Iron Metabolism in Cells 265 of
- Page 267 and 268:
VI. Iron Metabolism in Cells 267 in
- Page 269 and 270:
VII. Tests for Evaluating Iron Meta
- Page 271 and 272:
VII. Tests for Evaluating Iron Meta
- Page 273 and 274:
VIII. Disorders of Iron Metabolism
- Page 275 and 276:
VIII. Disorders of Iron Metabolism
- Page 277 and 278:
VIII. Disorders of Iron Metabolism
- Page 279 and 280:
References 279 ( Norrdin et al ., 2
- Page 281 and 282:
References 281 Fresco , R. ( 1981 )
- Page 283 and 284:
References 283 Moore , C. V. , Duba
- Page 285 and 286:
References 285 Weiden , P. L. , Hac
- Page 287 and 288:
288 Chapter | 10 Hemostasis TABLE 1
- Page 289 and 290:
290 Chapter | 10 Hemostasis TABLE 1
- Page 291 and 292:
292 Chapter | 10 Hemostasis The pro
- Page 293 and 294:
294 Chapter | 10 Hemostasis exhibit
- Page 295 and 296:
296 Chapter | 10 Hemostasis TABLE 1
- Page 297 and 298:
298 Chapter | 10 Hemostasis that is
- Page 299 and 300:
300 Chapter | 10 Hemostasis TABLE 1
- Page 301 and 302:
302 Chapter | 10 Hemostasis However
- Page 303 and 304:
304 Chapter | 10 Hemostasis 2. Comp
- Page 305 and 306:
306 Chapter | 10 Hemostasis is a re
- Page 307 and 308:
308 Chapter | 10 Hemostasis 2. Asse
- Page 309 and 310:
310 Chapter | 10 Hemostasis necessi
- Page 311 and 312:
312 Chapter | 10 Hemostasis disease
- Page 313 and 314:
314 Chapter | 10 Hemostasis concent
- Page 315 and 316:
316 Chapter | 10 Hemostasis the rol
- Page 317 and 318:
318 Chapter | 10 Hemostasis proport
- Page 319 and 320:
320 Chapter | 10 Hemostasis a consi
- Page 321 and 322:
322 Chapter | 10 Hemostasis Bakhtia
- Page 323 and 324:
324 Chapter | 10 Hemostasis Dowd ,
- Page 325 and 326:
326 Chapter | 10 Hemostasis Kier ,
- Page 327 and 328:
328 Chapter | 10 Hemostasis Nielsen
- Page 329 and 330:
330 Chapter | 10 Hemostasis Tablin
- Page 331 and 332:
332 Chapter | 11 Neutrophil Functio
- Page 333 and 334:
334 Chapter | 11 Neutrophil Functio
- Page 335 and 336:
336 Chapter | 11 Neutrophil Functio
- Page 337 and 338:
338 Chapter | 11 Neutrophil Functio
- Page 339 and 340:
340 Chapter | 11 Neutrophil Functio
- Page 341 and 342:
342 Chapter | 11 Neutrophil Functio
- Page 343 and 344:
344 Chapter | 11 Neutrophil Functio
- Page 345 and 346:
346 Chapter | 11 Neutrophil Functio
- Page 347 and 348:
348 Chapter | 11 Neutrophil Functio
- Page 349 and 350:
350 Chapter | 11 Neutrophil Functio
- Page 351 and 352:
352 Chapter | 12 Diagnostic Enzymol
- Page 353 and 354:
354 Chapter | 12 Diagnostic Enzymol
- Page 355 and 356:
356 Chapter | 12 Diagnostic Enzymol
- Page 357 and 358:
358 Chapter | 12 Diagnostic Enzymol
- Page 359 and 360:
360 Chapter | 12 Diagnostic Enzymol
- Page 361 and 362:
362 Chapter | 12 Diagnostic Enzymol
- Page 363 and 364:
364 Chapter | 12 Diagnostic Enzymol
- Page 365 and 366:
366 Chapter | 12 Diagnostic Enzymol
- Page 367 and 368:
368 Chapter | 12 Diagnostic Enzymol
- Page 369 and 370:
370 Chapter | 12 Diagnostic Enzymol
- Page 371 and 372:
372 Chapter | 12 Diagnostic Enzymol
- Page 373 and 374:
374 Chapter | 12 Diagnostic Enzymol
- Page 375 and 376:
376 Chapter | 12 Diagnostic Enzymol
- Page 377 and 378:
378 Chapter | 12 Diagnostic Enzymol
- Page 379 and 380:
380 Chapter | 13 Hepatic Function L
- Page 381 and 382:
382 Chapter | 13 Hepatic Function e
- Page 383 and 384:
384 Chapter | 13 Hepatic Function p
- Page 385 and 386:
386 Chapter | 13 Hepatic Function m
- Page 387 and 388:
388 Chapter | 13 Hepatic Function s
- Page 389 and 390:
390 Chapter | 13 Hepatic Function f
- Page 391 and 392:
392 Chapter | 13 Hepatic Function T
- Page 393 and 394:
394 Chapter | 13 Hepatic Function 2
- Page 395 and 396:
396 Chapter | 13 Hepatic Function u
- Page 397 and 398:
398 Chapter | 13 Hepatic Function 2
- Page 399 and 400:
400 Chapter | 13 Hepatic Function c
- Page 401 and 402:
402 Chapter | 13 Hepatic Function F
- Page 403 and 404:
404 Chapter | 13 Hepatic Function A
- Page 405 and 406:
406 Chapter | 13 Hepatic Function E
- Page 407 and 408:
408 Chapter | 13 Hepatic Function K
- Page 409 and 410:
410 Chapter | 13 Hepatic Function R
- Page 411 and 412:
412 Chapter | 13 Hepatic Function W
- Page 413 and 414:
414 Chapter | 14 Gastrointestinal F
- Page 415 and 416:
416 Chapter | 14 Gastrointestinal F
- Page 417 and 418:
418 Chapter | 14 Gastrointestinal F
- Page 419 and 420:
420 Chapter | 14 Gastrointestinal F
- Page 421 and 422:
422 Chapter | 14 Gastrointestinal F
- Page 423 and 424:
424 Chapter | 14 Gastrointestinal F
- Page 425 and 426:
426 Chapter | 14 Gastrointestinal F
- Page 427 and 428:
428 Chapter | 14 Gastrointestinal F
- Page 429 and 430:
430 Chapter | 14 Gastrointestinal F
- Page 431 and 432:
432 Chapter | 14 Gastrointestinal F
- Page 433 and 434:
434 Chapter | 14 Gastrointestinal F
- Page 435 and 436:
436 Chapter | 14 Gastrointestinal F
- Page 437 and 438:
438 Chapter | 14 Gastrointestinal F
- Page 439 and 440:
440 Chapter | 14 Gastrointestinal F
- Page 441 and 442:
442 Chapter | 14 Gastrointestinal F
- Page 443 and 444:
444 Chapter | 14 Gastrointestinal F
- Page 445 and 446:
446 Chapter | 14 Gastrointestinal F
- Page 447 and 448:
448 Chapter | 14 Gastrointestinal F
- Page 449 and 450:
450 Chapter | 14 Gastrointestinal F
- Page 451 and 452:
452 Chapter | 14 Gastrointestinal F
- Page 453 and 454:
454 Chapter | 14 Gastrointestinal F
- Page 455 and 456:
456 Chapter | 14 Gastrointestinal F
- Page 457 and 458:
Chapter 15 Skeletal Muscle Function
- Page 459 and 460:
II. Specialization of the Sarcolemm
- Page 461 and 462:
II. Specialization of the Sarcolemm
- Page 463 and 464:
III. Heterogeneity of Skeletal Musc
- Page 465 and 466:
III. Heterogeneity of Skeletal Musc
- Page 467 and 468:
V. Exercise and Adaptations to Trai
- Page 469 and 470:
VI. Diagnostic Laboratory Methods f
- Page 471 and 472:
VI. Diagnostic Laboratory Methods f
- Page 473 and 474:
IX. Selected Neuromuscular Disorder
- Page 475 and 476:
IX. Selected Neuromuscular Disorder
- Page 477 and 478:
References 479 and, recently, there
- Page 479 and 480:
References 481 Engel , A. G. ( 2004
- Page 481 and 482:
References 483 Paciello , O. , Maio
- Page 483 and 484:
Chapter 16 Kidney Function and Dama
- Page 485 and 486:
II. Kidney Morphology and Function
- Page 487 and 488:
II. Kidney Morphology and Function
- Page 489 and 490:
III. Tests of Kidney Function 491 (
- Page 491 and 492:
III. Tests of Kidney Function 493 T
- Page 493 and 494:
III. Tests of Kidney Function 495 B
- Page 495 and 496:
6 5 4 3 2 1 0 Dog Cat Equine Cattle
- Page 497 and 498:
III. Tests of Kidney Function 499 d
- Page 499 and 500:
IV. Tests of Kidney Damage 501 1000
- Page 501 and 502:
IV. Tests of Kidney Damage 503 and
- Page 503 and 504:
IV. Tests of Kidney Damage 505 Enzy
- Page 505 and 506:
V. Biochemical Changes in Kidney Di
- Page 507 and 508:
V. Biochemical Changes in Kidney Di
- Page 509 and 510:
References 511 were reported to occ
- Page 511 and 512:
References 513 Bovee , K. C. ( 1969
- Page 513 and 514:
References 515 Deguchi , E. , and A
- Page 515 and 516:
References 517 Fleming , S. A. , Hu
- Page 517 and 518:
References 519 Harvey , D. G. ( 197
- Page 519 and 520:
References 521 Kühl , S. , Mischke
- Page 521 and 522:
References 523 creatinine measureme
- Page 523 and 524:
References 525 Reusch , C. , Vochez
- Page 525 and 526:
References 527 Terry , R. , Hawkins
- Page 527 and 528:
Chapter 17 Fluid, Electrolyte, and
- Page 530 and 531:
532 Chapter | 17 Fluid, Electrolyte
- Page 534 and 535:
536 Chapter | 17 Fluid, Electrolyte
- Page 536 and 537:
538 Chapter | 17 Fluid, Electrolyte
- Page 538 and 539:
540 Chapter | 17 Fluid, Electrolyte
- Page 540 and 541:
542 Chapter | 17 Fluid, Electrolyte
- Page 542 and 543:
544 Chapter | 17 Fluid, Electrolyte
- Page 544 and 545:
546 Chapter | 17 Fluid, Electrolyte
- Page 546 and 547:
548 Chapter | 17 Fluid, Electrolyte
- Page 548 and 549:
550 Chapter | 17 Fluid, Electrolyte
- Page 551 and 552:
VIII. Clinicopathological Indicator
- Page 553 and 554:
References 555 plasma water, electr
- Page 555 and 556:
References 557 Krzywanek , H. ( 197
- Page 557 and 558:
References 559 Strombeck , D. R. (1
- Page 559 and 560:
562 Chapter | 18 Pituitary Function
- Page 561 and 562:
564 Chapter | 18 Pituitary Function
- Page 563 and 564:
566 Chapter | 18 Pituitary Function
- Page 565 and 566:
568 Chapter | 18 Pituitary Function
- Page 567 and 568:
570 Chapter | 18 Pituitary Function
- Page 569 and 570:
572 Chapter | 18 Pituitary Function
- Page 571 and 572:
574 Chapter | 18 Pituitary Function
- Page 573 and 574:
576 Chapter | 18 Pituitary Function
- Page 575 and 576:
578 Chapter | 18 Pituitary Function
- Page 577 and 578:
580 Chapter | 18 Pituitary Function
- Page 579 and 580:
582 Chapter | 18 Pituitary Function
- Page 581 and 582:
584 Chapter | 18 Pituitary Function
- Page 583 and 584:
586 Chapter | 18 Pituitary Function
- Page 585 and 586:
588 Chapter | 18 Pituitary Function
- Page 587 and 588:
590 Chapter | 18 Pituitary Function
- Page 589 and 590:
592 Chapter | 18 Pituitary Function
- Page 591 and 592:
594 Chapter | 18 Pituitary Function
- Page 593 and 594:
596 Chapter | 18 Pituitary Function
- Page 595 and 596:
598 Chapter | 18 Pituitary Function
- Page 597 and 598:
600 Chapter | 18 Pituitary Function
- Page 599 and 600:
602 Chapter | 18 Pituitary Function
- Page 601 and 602:
604 Chapter | 18 Pituitary Function
- Page 603 and 604:
606 Chapter | 19 Adrenocortical Fun
- Page 605 and 606:
608 Chapter | 19 Adrenocortical Fun
- Page 607 and 608:
610 Chapter | 19 Adrenocortical Fun
- Page 609 and 610:
612 Chapter | 19 Adrenocortical Fun
- Page 611 and 612:
614 Chapter | 19 Adrenocortical Fun
- Page 613 and 614:
616 Chapter | 19 Adrenocortical Fun
- Page 615 and 616:
618 Chapter | 19 Adrenocortical Fun
- Page 617 and 618:
620 Chapter | 19 Adrenocortical Fun
- Page 619 and 620:
622 Chapter | 19 Adrenocortical Fun
- Page 621 and 622:
624 Chapter | 20 Thyroid Function a
- Page 623 and 624:
626 Chapter | 20 Thyroid Function t
- Page 625 and 626:
628 Chapter | 20 Thyroid Function A
- Page 627 and 628:
630 Chapter | 20 Thyroid Function S
- Page 629 and 630:
632 Chapter | 20 Thyroid Function a
- Page 631 and 632:
634 Chapter | 20 Thyroid Function O
- Page 633 and 634:
636 Chapter | 21 Clinical Reproduct
- Page 635 and 636:
638 Chapter | 21 Clinical Reproduct
- Page 637 and 638:
640 Chapter | 21 Clinical Reproduct
- Page 639 and 640:
642 Chapter | 21 Clinical Reproduct
- Page 641 and 642:
644 Chapter | 21 Clinical Reproduct
- Page 643 and 644:
646 Chapter | 21 Clinical Reproduct
- Page 645 and 646:
648 Chapter | 21 Clinical Reproduct
- Page 647 and 648:
650 Chapter | 21 Clinical Reproduct
- Page 649 and 650:
652 Chapter | 21 Clinical Reproduct
- Page 651 and 652:
654 Chapter | 21 Clinical Reproduct
- Page 653 and 654:
656 Chapter | 21 Clinical Reproduct
- Page 655 and 656:
658 Chapter | 21 Clinical Reproduct
- Page 657 and 658:
660 Chapter | 21 Clinical Reproduct
- Page 659 and 660:
662 Chapter | 21 Clinical Reproduct
- Page 661 and 662:
664 Chapter | 22 Trace Minerals the
- Page 663 and 664:
666 Chapter | 22 Trace Minerals the
- Page 665 and 666:
668 Chapter | 22 Trace Minerals P i
- Page 667 and 668:
670 Chapter | 22 Trace Minerals be
- Page 669 and 670:
Copper Cuproreductase Cytochromes C
- Page 671 and 672:
674 Chapter | 22 Trace Minerals 2 .
- Page 673 and 674:
676 Chapter | 22 Trace Minerals Cor
- Page 675 and 676:
678 Chapter | 22 Trace Minerals inf
- Page 677 and 678:
680 Chapter | 22 Trace Minerals tis
- Page 679 and 680:
682 Chapter | 22 Trace Minerals VI
- Page 681 and 682:
684 Chapter | 22 Trace Minerals red
- Page 683 and 684:
686 Chapter | 22 Trace Minerals of
- Page 685 and 686:
688 Chapter | 22 Trace Minerals Per
- Page 687 and 688: 690 Chapter | 22 Trace Minerals In
- Page 689 and 690: 692 Chapter | 22 Trace Minerals Liu
- Page 691 and 692: Chapter 23 Vitamins Robert B. Rucke
- Page 693 and 694: III. Fat-Soluble Vitamins 697 TABLE
- Page 695 and 696: III. Fat-Soluble Vitamins 699 Carot
- Page 697 and 698: III. Fat-Soluble Vitamins 701 Major
- Page 699 and 700: III. Fat-Soluble Vitamins 703 doses
- Page 701 and 702: III. Fat-Soluble Vitamins 705 Diet
- Page 703 and 704: III. Fat-Soluble Vitamins 707 conta
- Page 705 and 706: III. Fat-Soluble Vitamins 709 immun
- Page 707 and 708: IV. Water-Soluble Vitamins 711 are
- Page 709 and 710: IV. Water-Soluble Vitamins 713 abil
- Page 711 and 712: IV. Water-Soluble Vitamins 715 5’
- Page 713 and 714: IV. Water-Soluble Vitamins 717 H 2
- Page 715 and 716: IV. Water-Soluble Vitamins 719 Enzy
- Page 718 and 719: 722 Chapter | 23 Vitamins When biot
- Page 720 and 721: 724 Chapter | 23 Vitamins Cyanocoba
- Page 722 and 723: 726 Chapter | 23 Vitamins V . VITAM
- Page 724 and 725: 728 Chapter | 23 Vitamins nature, r
- Page 726 and 727: 730 Chapter | 23 Vitamins Stites ,
- Page 728 and 729: 732 Chapter | 24 Lysosomal Storage
- Page 730 and 731: 734 Chapter | 24 Lysosomal Storage
- Page 732 and 733: 736 Chapter | 24 Lysosomal Storage
- Page 734 and 735: 738 Chapter | 24 Lysosomal Storage
- Page 736 and 737: 740 Chapter | 24 Lysosomal Storage
- Page 740 and 741: 744 Chapter | 24 Lysosomal Storage
- Page 742 and 743: 746 Chapter | 24 Lysosomal Storage
- Page 744 and 745: 748 Chapter | 24 Lysosomal Storage
- Page 746 and 747: Chapter 25 Tumor Markers Michael D.
- Page 748 and 749: II. Serum Tumor Markers 753 also be
- Page 750 and 751: III. Flow Cytometry 755 cancer of t
- Page 752 and 753: V. Immunohistochemistry/Immunocytoc
- Page 754 and 755: V. Immunohistochemistry/Immunocytoc
- Page 756 and 757: References 761 analysis will facili
- Page 758 and 759: References 763 Fernandez , N. J. ,
- Page 760 and 761: References 765 Meinecke , B. , and
- Page 762 and 763: References 767 Walter , J. ( 2000 )
- Page 764 and 765: 770 Chapter | 26 Cerebrospinal Flui
- Page 766 and 767: 772 Chapter | 26 Cerebrospinal Flui
- Page 768 and 769: 774 Chapter | 26 Cerebrospinal Flui
- Page 770 and 771: 776 Chapter | 26 Cerebrospinal Flui
- Page 772 and 773: 778 Chapter | 26 Cerebrospinal Flui
- Page 774 and 775: TABLE 26-7 Continued Constituent Ro
- Page 776 and 777: 782 Chapter | 26 Cerebrospinal Flui
- Page 778 and 779: 784 Chapter | 26 Cerebrospinal Flui
- Page 780 and 781: 786 Chapter | 26 Cerebrospinal Flui
- Page 782 and 783: 788 Chapter | 26 Cerebrospinal Flui
- Page 784 and 785: 790 Chapter | 26 Cerebrospinal Flui
- Page 786 and 787: 792 Chapter | 26 Cerebrospinal Flui
- Page 788 and 789:
794 Chapter | 26 Cerebrospinal Flui
- Page 790 and 791:
796 Chapter | 26 Cerebrospinal Flui
- Page 792 and 793:
798 Chapter | 26 Cerebrospinal Flui
- Page 794 and 795:
800 Chapter | 26 Cerebrospinal Flui
- Page 796 and 797:
802 Chapter | 26 Cerebrospinal Flui
- Page 798 and 799:
804 Chapter | 26 Cerebrospinal Flui
- Page 800 and 801:
806 Chapter | 26 Cerebrospinal Flui
- Page 802 and 803:
808 Chapter | 26 Cerebrospinal Flui
- Page 804 and 805:
810 Chapter | 26 Cerebrospinal Flui
- Page 806 and 807:
812 Chapter | 26 Cerebrospinal Flui
- Page 808 and 809:
814 Chapter | 26 Cerebrospinal Flui
- Page 810 and 811:
816 Chapter | 26 Cerebrospinal Flui
- Page 812 and 813:
818 Chapter | 26 Cerebrospinal Flui
- Page 814 and 815:
Chapter 27 Clinical Biochemistry in
- Page 816 and 817:
II. Hepatotoxicity 823 Therefore, A
- Page 818 and 819:
III. Nephrotoxicity 825 suggested a
- Page 820 and 821:
IV. Toxins Affecting Skeletal and C
- Page 822 and 823:
VII. Toxins Affecting Erythrocytes
- Page 824 and 825:
VIII. Toxins Affecting Hemoglobin a
- Page 826 and 827:
IX. Toxins Affecting the Nervous Sy
- Page 828 and 829:
References 835 Plants classified as
- Page 830 and 831:
References 837 Solaiman , S. G. , M
- Page 832 and 833:
840 Chapter | 28 Avian Clinical Bio
- Page 834 and 835:
842 Chapter | 28 Avian Clinical Bio
- Page 836 and 837:
844 Chapter | 28 Avian Clinical Bio
- Page 838 and 839:
846 Chapter | 28 Avian Clinical Bio
- Page 840 and 841:
848 Chapter | 28 Avian Clinical Bio
- Page 842 and 843:
850 Chapter | 28 Avian Clinical Bio
- Page 844 and 845:
Budgerigar ALAT (IU/g tissue) Budge
- Page 846 and 847:
854 Chapter | 28 Avian Clinical Bio
- Page 848 and 849:
856 Chapter | 28 Avian Clinical Bio
- Page 850 and 851:
858 Chapter | 28 Avian Clinical Bio
- Page 852 and 853:
860 Chapter | 28 Avian Clinical Bio
- Page 854 and 855:
862 Chapter | 28 Avian Clinical Bio
- Page 856 and 857:
864 Chapter | 28 Avian Clinical Bio
- Page 858 and 859:
866 Chapter | 28 Avian Clinical Bio
- Page 860 and 861:
868 Chapter | 28 Avian Clinical Bio
- Page 862 and 863:
870 Chapter | 28 Avian Clinical Bio
- Page 864 and 865:
872 Chapter | 28 Avian Clinical Bio
- Page 866 and 867:
874 Appendix | I SI Units TABLE E S
- Page 868 and 869:
Appendix II Conversion Factors of S
- Page 870 and 871:
Appendix IV Stability of Serum Enzy
- Page 872 and 873:
Appendix VI Nomogram for Computing
- Page 874 and 875:
t0100 Appendix VIII Blood Analyte R
- Page 876 and 877:
884 Appendix | VIII Blood Analyte R
- Page 878 and 879:
886 Appendix | VIII Blood Analyte R
- Page 880 and 881:
888 Appendix | VIII Blood Analyte R
- Page 882 and 883:
890 Appendix | IX Blood Analyte Ref
- Page 884 and 885:
892 Appendix | IX Blood Analyte Ref
- Page 886 and 887:
894 Appendix | IX Blood Analyte Ref
- Page 888 and 889:
Appendix X Blood Analyte Reference
- Page 890 and 891:
Appendix XI Blood Analyte Reference
- Page 892 and 893:
Appendix XII Urine Analyte Referenc
- Page 894 and 895:
902 Appendix | XIII Cerebrospinal F
- Page 896:
904 Appendix | XIV Cerebrospinal Fl